| UniProt ID | UB2Q1_HUMAN | |
|---|---|---|
| UniProt AC | Q7Z7E8 | |
| Protein Name | Ubiquitin-conjugating enzyme E2 Q1 | |
| Gene Name | UBE2Q1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 422 | |
| Subcellular Localization | Nucleus . Cell projection, filopodium . Cytoplasm, cytosol . | |
| Protein Description | Catalyzes the covalent attachment of ubiquitin to other proteins. [PubMed: 22496338 May be involved in hormonal homeostasis in females. Involved in regulation of B4GALT1 cell surface expression, B4GALT1-mediated cell adhesion to laminin and embryoid body formation (By similarity] | |
| Protein Sequence | MQQPQPQGQQQPGPGQQLGGQGAAPGAGGGPGGGPGPGPCLRRELKLLESIFHRGHERFRIASACLDELSCEFLLAGAGGAGAGAAPGPHLPPRGSVPGDPVRIHCNITESYPAVPPIWSVESDDPNLAAVLERLVDIKKGNTLLLQHLKRIISDLCKLYNLPQHPDVEMLDQPLPAEQCTQEDVSSEDEDEEMPEDTEDLDHYEMKEEEPAEGKKSEDDGIGKENLAILEKIKKNQRQDYLNGAVSGSVQATDRLMKELRDIYRSQSFKGGNYAVELVNDSLYDWNVKLLKVDQDSALHNDLQILKEKEGADFILLNFSFKDNFPFDPPFVRVVSPVLSGGYVLGGGAICMELLTKQGWSSAYSIESVIMQISATLVKGKARVQFGANKSQYSLTRAQQSYKSLVQIHEKNGWYTPPKEDG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MQQPQPQG -------CCCCCCCC | 8.24 | 22223895 | |
| 46 | Ubiquitination | PCLRRELKLLESIFH HHHHHHHHHHHHHHH | 46.39 | 23000965 | |
| 46 (in isoform 1) | Ubiquitination | - | 46.39 | 21890473 | |
| 46 | Ubiquitination | PCLRRELKLLESIFH HHHHHHHHHHHHHHH | 46.39 | 21890473 | |
| 46 | Acetylation | PCLRRELKLLESIFH HHHHHHHHHHHHHHH | 46.39 | 23236377 | |
| 50 | Phosphorylation | RELKLLESIFHRGHE HHHHHHHHHHHHCHH | 30.44 | 28857561 | |
| 96 | Phosphorylation | PHLPPRGSVPGDPVR CCCCCCCCCCCCCEE | 26.81 | - | |
| 139 | Sumoylation | LERLVDIKKGNTLLL HHHHHCHHCCCHHHH | 50.60 | - | |
| 139 | Sumoylation | LERLVDIKKGNTLLL HHHHHCHHCCCHHHH | 50.60 | - | |
| 140 | Ubiquitination | ERLVDIKKGNTLLLQ HHHHCHHCCCHHHHH | 58.70 | 29967540 | |
| 217 | Phosphorylation | EPAEGKKSEDDGIGK CCCCCCCCCCCCCCH | 50.14 | 24719451 | |
| 224 | Ubiquitination | SEDDGIGKENLAILE CCCCCCCHHHHHHHH | 41.32 | 29967540 | |
| 232 | Acetylation | ENLAILEKIKKNQRQ HHHHHHHHHHHCCCH | 57.28 | 20167786 | |
| 232 | Ubiquitination | ENLAILEKIKKNQRQ HHHHHHHHHHHCCCH | 57.28 | 33845483 | |
| 234 | Acetylation | LAILEKIKKNQRQDY HHHHHHHHHCCCHHH | 57.66 | 20167786 | |
| 241 | Phosphorylation | KKNQRQDYLNGAVSG HHCCCHHHHHCHHCC | 8.17 | - | |
| 247 | Phosphorylation | DYLNGAVSGSVQATD HHHHCHHCCHHHHHH | 25.47 | 22817900 | |
| 264 | Phosphorylation | MKELRDIYRSQSFKG HHHHHHHHHHCCCCC | 14.43 | - | |
| 266 | Phosphorylation | ELRDIYRSQSFKGGN HHHHHHHHCCCCCCC | 17.13 | 28450419 | |
| 268 | Phosphorylation | RDIYRSQSFKGGNYA HHHHHHCCCCCCCEE | 30.12 | 28450419 | |
| 274 | Phosphorylation | QSFKGGNYAVELVND CCCCCCCEEEEECCC | 18.46 | 28450419 | |
| 307 | Ubiquitination | HNDLQILKEKEGADF HHHHHHHHHHCCCCE | 69.26 | 33845483 | |
| 309 | Ubiquitination | DLQILKEKEGADFIL HHHHHHHHCCCCEEE | 60.92 | 33845483 | |
| 320 | Phosphorylation | DFILLNFSFKDNFPF CEEEEECCCCCCCCC | 30.25 | 24719451 | |
| 390 | Ubiquitination | RVQFGANKSQYSLTR EEEECCCHHHHCHHH | 38.10 | 29967540 | |
| 390 | Acetylation | RVQFGANKSQYSLTR EEEECCCHHHHCHHH | 38.10 | 26051181 | |
| 391 | Phosphorylation | VQFGANKSQYSLTRA EEECCCHHHHCHHHH | 33.87 | 28796482 | |
| 393 | Phosphorylation | FGANKSQYSLTRAQQ ECCCHHHHCHHHHHH | 16.85 | 28796482 | |
| 394 | Phosphorylation | GANKSQYSLTRAQQS CCCHHHHCHHHHHHH | 18.67 | 28857561 | |
| 396 | Phosphorylation | NKSQYSLTRAQQSYK CHHHHCHHHHHHHHH | 20.30 | 28796482 | |
| 401 | Phosphorylation | SLTRAQQSYKSLVQI CHHHHHHHHHHHHHH | 23.58 | 28857561 | |
| 403 | Ubiquitination | TRAQQSYKSLVQIHE HHHHHHHHHHHHHHH | 42.43 | 32015554 | |
| 404 | Phosphorylation | RAQQSYKSLVQIHEK HHHHHHHHHHHHHHH | 26.07 | 28857561 | |
| 415 | Phosphorylation | IHEKNGWYTPPKEDG HHHHCCCCCCCCCCC | 15.69 | 22817900 | |
| 416 | Phosphorylation | HEKNGWYTPPKEDG- HHHCCCCCCCCCCC- | 26.97 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UB2Q1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UB2Q1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UB2Q1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| I2BPL_HUMAN | IRF2BPL | physical | 19690564 | |
| RNF26_HUMAN | RNF26 | physical | 19690564 | |
| RBX2_HUMAN | RNF7 | physical | 19549727 | |
| ECM29_HUMAN | KIAA0368 | physical | 20682791 | |
| CHIP_HUMAN | STUB1 | physical | 16275660 | |
| P53_HUMAN | TP53 | physical | 25987028 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |